Lawrence F Kelly

Title: The Innovations of Lawrence F Kelly

Introduction

Lawrence F Kelly is a notable inventor based in Canberra, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antineoplastic activity. With a total of 5 patents to his name, his work has had a considerable impact on cancer treatment.

Latest Patents

Among his latest patents are the 8,10-Dideazaminopterins, which include 10-Alkyl-8,10-dideazaminopterins. These compounds are described by the formula ##STR1## where R is hydrogen or an alkyl group containing 1 to about 8 carbon atoms. Their carboxylate and acid addition salts are also included in the patent. These compounds exhibit antineoplastic activity that is similar to, but more effective than, methotrexate. Another patent focuses on 8,10-Dideazaminopterins, which are also described by the formula ##STR1## where R is hydrogen or an alkyl group of 1 to about 8 carbon atoms. These compounds, too, show antineoplastic activity that surpasses that of methotrexate.

Career Highlights

Throughout his career, Lawrence F Kelly has worked with prominent organizations such as Imperial Chemical Industries Limited and SRI International. His work in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include James R Jennings and Philip J Hogan. Their collaboration has contributed to the advancement of research and development in their respective fields.

Conclusion

Lawrence F Kelly's contributions to the field of pharmaceuticals, particularly through his innovative patents, have made a significant impact on cancer treatment. His work continues to inspire future innovations in the industry.